Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma in a 4-Year-old Girl
Ruoqu Wei,Haoyu Wang,Jie Zhang,Zhen Zhang,Zhirong Yao
DOI: https://doi.org/10.1111/ijd.16985
2024-01-01
International Journal of Dermatology
Abstract:International Journal of DermatologyEarly View Case Report Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma in a 4-year-old girl Ruoqu Wei PhD, Ruoqu Wei PhD Dermatology Center, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China Department of Dermatology, Shanghai Jiaotong University School of Medicine, Shanghai, China Institute of Dermatology, Shanghai Jiaotong University School of Medicine, Shanghai, China Ruoqu Wei and Haoyu Wang contributed equally to the work.Search for more papers by this authorHaoyu Wang PhD, Haoyu Wang PhD Dermatology Center, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China Department of Dermatology, Shanghai Jiaotong University School of Medicine, Shanghai, China Institute of Dermatology, Shanghai Jiaotong University School of Medicine, Shanghai, China Ruoqu Wei and Haoyu Wang contributed equally to the work.Search for more papers by this authorJie Zhang MS, Jie Zhang MS The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, ChinaSearch for more papers by this authorZhen Zhang PhD, Zhen Zhang PhD orcid.org/0000-0003-1344-9272 Dermatology Center, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China Department of Dermatology, Shanghai Jiaotong University School of Medicine, Shanghai, China Institute of Dermatology, Shanghai Jiaotong University School of Medicine, Shanghai, ChinaSearch for more papers by this authorZhirong Yao PhD, MD, Corresponding Author Zhirong Yao PhD, MD [email protected] Dermatology Center, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China Department of Dermatology, Shanghai Jiaotong University School of Medicine, Shanghai, China Institute of Dermatology, Shanghai Jiaotong University School of Medicine, Shanghai, China Correspondence Zhirong Yao, PhD, MD Department of Dermatology Xinhua Hospital Shanghai Jiaotong University School of Medicine 1665 Kongjiang Road Shanghai 200092 China E-mail: [email protected]Search for more papers by this author Ruoqu Wei PhD, Ruoqu Wei PhD Dermatology Center, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China Department of Dermatology, Shanghai Jiaotong University School of Medicine, Shanghai, China Institute of Dermatology, Shanghai Jiaotong University School of Medicine, Shanghai, China Ruoqu Wei and Haoyu Wang contributed equally to the work.Search for more papers by this authorHaoyu Wang PhD, Haoyu Wang PhD Dermatology Center, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China Department of Dermatology, Shanghai Jiaotong University School of Medicine, Shanghai, China Institute of Dermatology, Shanghai Jiaotong University School of Medicine, Shanghai, China Ruoqu Wei and Haoyu Wang contributed equally to the work.Search for more papers by this authorJie Zhang MS, Jie Zhang MS The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, ChinaSearch for more papers by this authorZhen Zhang PhD, Zhen Zhang PhD orcid.org/0000-0003-1344-9272 Dermatology Center, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China Department of Dermatology, Shanghai Jiaotong University School of Medicine, Shanghai, China Institute of Dermatology, Shanghai Jiaotong University School of Medicine, Shanghai, ChinaSearch for more papers by this authorZhirong Yao PhD, MD, Corresponding Author Zhirong Yao PhD, MD [email protected] Dermatology Center, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China Department of Dermatology, Shanghai Jiaotong University School of Medicine, Shanghai, China Institute of Dermatology, Shanghai Jiaotong University School of Medicine, Shanghai, China Correspondence Zhirong Yao, PhD, MD Department of Dermatology Xinhua Hospital Shanghai Jiaotong University School of Medicine 1665 Kongjiang Road Shanghai 200092 China E-mail: [email protected]Search for more papers by this author First published: 23 January 2024 https://doi.org/10.1111/ijd.16985 Conflict of interest: None. Funding source: This work was supported by funds from the National Nature Science Foundation of China (82203937, 82203949), Shanghai Sailing Program Discipline in Shanghai (22YF1427000, 22YF1436600). Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1Paulli M, Berti E. Cutaneous T-cell lymphomas (including rare subtypes): current concepts, II. Haematologica. 2004; 89(11): 1372–1388. PubMedWeb of Science®Google Scholar 2Kempf W, Sander CA. Classification of cutaneous lymphomase an update. Histopathology. 2010; 56: 57–70. 10.1111/j.1365-2559.2009.03455.x CASPubMedWeb of Science®Google Scholar 3Diwan H, Evan D. CD8-positive mycosis fungoides and primary cutaneous aggressive epidermotropic CD8-positive cytotoxic T-cell lymphoma. J Cutan Pathol. 2009; 36(3): 390–392. 10.1111/j.1600-0560.2008.01259.x CASPubMedWeb of Science®Google Scholar 4Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005; 105(10): 3768–3785. 10.1182/blood-2004-09-3502 CASPubMedWeb of Science®Google Scholar 5Geller S, Myskowski PL, Pulitzer M. NK/T-cell lymphoma, nasal type, γδ T-cell lymphoma, and CD8-positive epidermotropic T-cell lymphoma—clinical and histopathologic features, differential diagnosis, and treatment. Semin Cutan Med Surg. 2018; 37(1): 30–38. 10.12788/j.sder.2018.015 PubMedWeb of Science®Google Scholar 6Rook AH, Junkins-Hopkins JM, McGinnis KS, Wysocka M, Richardson SK, Budgin JB, et al. Cytokines and other biologic agents as immunotherapeutics for cutaneous T-cell lymphoma. Adv Dermatol. 2002; 18: 29–43. PubMedGoogle Scholar 7Cheng D, Xu Q, Zhang W, Chen J, Yao Z. Refractory lymphomatoid papulosis successfully treated with IFN-α2a and photodynamic therapy. Int J Dermatol. 2023; 62(11): 1400–1403. 10.1111/ijd.16759 PubMedWeb of Science®Google Scholar 8Kim SK, Kim YC, Kang HY. Primary cutaneous aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma with atypical presentation. J Dermatol. 2006; 33(9): 632–634. 10.1111/j.1346-8138.2006.00147.x CASPubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation